全文获取类型
收费全文 | 4086篇 |
免费 | 390篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 74篇 |
儿科学 | 79篇 |
妇产科学 | 135篇 |
基础医学 | 476篇 |
口腔科学 | 83篇 |
临床医学 | 540篇 |
内科学 | 746篇 |
皮肤病学 | 44篇 |
神经病学 | 247篇 |
特种医学 | 111篇 |
外科学 | 568篇 |
综合类 | 133篇 |
一般理论 | 1篇 |
预防医学 | 524篇 |
眼科学 | 33篇 |
药学 | 348篇 |
中国医学 | 13篇 |
肿瘤学 | 323篇 |
出版年
2021年 | 60篇 |
2020年 | 48篇 |
2019年 | 63篇 |
2018年 | 58篇 |
2017年 | 57篇 |
2016年 | 51篇 |
2015年 | 81篇 |
2014年 | 101篇 |
2013年 | 127篇 |
2012年 | 239篇 |
2011年 | 262篇 |
2010年 | 99篇 |
2009年 | 105篇 |
2008年 | 145篇 |
2007年 | 204篇 |
2006年 | 214篇 |
2005年 | 165篇 |
2004年 | 180篇 |
2003年 | 174篇 |
2002年 | 126篇 |
2001年 | 124篇 |
2000年 | 140篇 |
1999年 | 115篇 |
1998年 | 42篇 |
1997年 | 37篇 |
1996年 | 29篇 |
1995年 | 31篇 |
1993年 | 29篇 |
1992年 | 110篇 |
1991年 | 99篇 |
1990年 | 76篇 |
1989年 | 75篇 |
1988年 | 78篇 |
1987年 | 75篇 |
1986年 | 68篇 |
1985年 | 75篇 |
1984年 | 51篇 |
1983年 | 50篇 |
1982年 | 28篇 |
1981年 | 29篇 |
1980年 | 42篇 |
1979年 | 46篇 |
1978年 | 30篇 |
1976年 | 29篇 |
1975年 | 33篇 |
1974年 | 36篇 |
1973年 | 29篇 |
1972年 | 32篇 |
1971年 | 29篇 |
1970年 | 32篇 |
排序方式: 共有4478条查询结果,搜索用时 281 毫秒
1.
2.
Kevin L. Greason Juan A. Crestanello Katherine S. King Gabor Bagameri Sertac M. Cicek John M. Stulak Richard C. Daly Joseph A. Dearani Hartzell V. Schaff 《The Journal of thoracic and cardiovascular surgery》2021,161(1):12-20.e2
BackgroundThere is controversy regarding the extent of aortic resection necessary in patients with aortopathy related to bicuspid aortic valve disease. To address this issue, we reviewed our experience in patients undergoing ascending aorta replacement during bicuspid aortic valve replacement.MethodsWe reviewed 702 patients who underwent ascending aorta replacement at the time of initial nonemergent native bicuspid aortic valve replacement at our institution between January 2000 and June 2017. Treatment cohorts included an open hemiarch replacement group (n = 225; 32%) and a clamped ascending aorta replacement group (n = 477; 68%).ResultsMedian patient age was 60 years (interquartile range [IQR], 51-67 years), female sex was present in 113 patients (16%), ejection fraction was 62% (IQR, 56%-66%), and aortic arch diameter was 33 mm (IQR, 29-36 mm). Cardiopulmonary bypass time was longer in the hemiarch replacement group (188 minutes vs 97 minutes; P < .001). Procedure-related complications (36%) and mortality (<1%) were similar in the 2 groups; however, the hemiarch group had an increased odds of blood transfusion (odds ratio, 1.62; 95% confidence interval [CI], 1.15-2.28; P = .006). The median duration of follow-up was 6.0 years (95% CI, 5.3-6.8 years). Overall survival was 94 ± 1% at 5 years and 80 ± 2% at 10 years. Multivariable analysis demonstrated similar survival in the 2 groups (hazard ratio, 0.83; 95% CI, 0.51-1.33; P = .439). No repeat aortic arch operations were done for aortopathy over the duration of clinical follow-up.ConclusionsCompared with patients in the clamped ascending aorta replacement group, patients in the hemi-arch replacement group had longer cardiopulmonary bypass and aortic cross-clamp times, along with an increased risk of blood transfusion, but similar freedom from repeat aortic arch operation and survival. We identified no advantage of performing hemiarch replacement in the absence of aortic arch dilation. 相似文献
3.
D. Adkins J. Ley P. Oppelt H.A. Gay M. Daly R.C. Paniello R. Jackson P. Pipkorn J. Rich J. Zevallos K. Trinkaus W. Thorstad 《Clinical oncology (Royal College of Radiologists (Great Britain))》2019,31(9):e123-e131
AimsOrgan preservation, an important goal in the treatment of head and neck squamous cell carcinoma (HNSCC), may include induction chemotherapy and cisplatin with radiation therapy (CRT). To our knowledge, no reports have directly compared the impact of induction chemotherapy with that of CRT on health-related quality of life (HRQOL).Materials and methodsIn a phase II trial, we assessed the HRQOL of patients treated with induction chemotherapy followed by CRT. Eligible patients had stage III–IV HNSCC. HRQOL questionnaires were administered at baseline, the end of induction (EOI), the end of CRT (EOCRT) and after CRT. Functional Assessment of Cancer Therapy (FACT version 4) assessed HRQOL. We carried out a comparison of changes in HRQOL from baseline to EOI and from EOI to EOCRT. This trial is registered with ClinicalTrials.gov (NCT01566435).ResultsThirty patients were enrolled in the study. Most HRQOL questionnaires were completed (88%). The mean total FACT scores did not differ from baseline to EOI (general: 83.8 versus 79.1, P = 0.08; head and neck: 109.7 versus 105.8, P = 0.33; Total Outcome Index: 69.7 versus 62.3, P = 0.03; respectively, using P ≤ 0.01 to adjust for multiple simultaneous tests of differences). However, total FACT scores significantly worsened from EOI to EOCRT (79.1 versus 62.3, P = 0.01; 105.8 versus 74.2, P < 0.01; 62.3 versus 34.2, P = 0.01; respectively). Within domains, the head and neck cancer subscale score did not differ from baseline to EOI (median 28.5 versus 27.0, P = 0.69), but significantly worsened from EOI to EOCRT (27.0 versus 9.5, P < 0.01). Swallowing, oral pain and voice quality improved from baseline to EOI, but worsened from EOI to EOCRT. Physical and functional scores worsened from baseline to EOI and from EOI to EOCRT. The emotional well-being score improved from baseline to EOI but worsened from EOI to EOCRT.ConclusionsOverall, HRQOL did not significantly change from baseline to EOI but dramatically worsened from EOI to EOCRT. 相似文献
4.
5.
6.
7.
D. E. Stewart S. M. Tlusty K. H. Taylor R. S. Brown H. N. Neil D. K. Klassen J. A. Davis T. M. Daly P. C. Camp A. M. Doyle 《American journal of transplantation》2015,15(12):3123-3133
Analysis and dissemination of transplant patient safety data are essential to understanding key issues facing the transplant community and fostering a “culture of safety.” The Organ Procurement and Transplantation Network's (OPTN) Operations and Safety Committee de‐identified safety situations reported through several mechanisms, including the OPTN's online patient safety portal, through which the number of reported cases has risen sharply. From 2012 to 2013, 438 events were received through either the online portal or other reporting pathways, and about half were self‐reports. Communication breakdowns (22.8%) and testing issues (16.0%) were the most common types. Events included preventable errors that led to organ discard as well as near misses. Among events reported by Organ Procurement Organization (OPOs), half came from just 10 of the 58 institutions, while half of events reported by transplant centers came from just 21 of 250 institutions. Thirteen (23%) OPOs and 155 (62%) transplant centers reported no events, suggesting substantial underreporting of safety‐related errors to the national database. This is the first comprehensive, published report of the OPTN's safety efforts. Our goals are to raise awareness of safety data recently reported to the OPTN, encourage additional reporting, and spur systems improvements to mitigate future risk. 相似文献
8.
Higher Dietary Calcium Intakes Are Associated With Reduced Risks of Fractures,Cardiovascular Events,and Mortality: A Prospective Cohort Study of Older Men and Women 下载免费PDF全文
Belal Khan Caryl A Nowson Robin M Daly Dallas R English Allison M Hodge Graham G Giles Peter R Ebeling 《Journal of bone and mineral research》2015,30(10):1758-1766
The aim of this population‐based, prospective cohort study was to investigate long‐term associations between dietary calcium intake and fractures, non‐fatal cardiovascular disease (CVD), and death from all causes. Participants were from the Melbourne Collaborative Cohort Study, which was established in 1990 to 1994. A total of 41,514 men and women (~99% aged 40 to 69 years at baseline) were followed up for a mean (SD) of 12 (1.5) years. Primary outcome measures were time to death from all causes (n = 2855), CVD‐related deaths (n = 557), cerebrovascular disease‐related deaths (n = 139), incident non‐fatal CVD (n = 1827), incident stroke events (n = 537), and incident fractures (n = 788). A total of 12,097 participants (aged ≥50 years) were eligible for fracture analysis and 34,468 for non‐fatal CVD and mortality analyses. Mortality was ascertained by record linkage to registries. Fractures and CVD were ascertained from interview ~13 years after baseline. Quartiles of baseline energy‐adjusted calcium intake from food were estimated using a food‐frequency questionnaire. Hazard ratios (HR) and odds ratios (OR) were calculated for quartiles of dietary calcium intake. Highest and lowest quartiles of energy‐adjusted dietary calcium intakes represented unadjusted means (SD) of 1348 (316) mg/d and 473 (91) mg/d, respectively. Overall, there were 788 (10.3%) incident fractures, 1827 (9.0%) incident CVD, and 2855 people (8.6%) died. Comparing the highest with the lowest quartile of calcium intake, for all‐cause mortality, the HR was 0.86 (95% confidence interval [CI] 0.76–0.98, ptrend = 0.01); for non‐fatal CVD and stroke, the OR was 0.84 (95% CI 0.70–0.99, ptrend = 0.04) and 0.69 (95% CI 0.51–0.93, ptrend = 0.02), respectively; and the OR for fracture was 0.70 (95% CI 0.54–0.92, ptrend = 0.004). In summary, for older men and women, calcium intakes of up to 1348 (316) mg/d from food were associated with decreased risks for fracture, non‐fatal CVD, stroke, and all‐cause mortality. © 2015 American Society for Bone and Mineral Research. 相似文献
9.
10.